Contact the team

eGFR-C Study Office

eGFR-C Study Office
Birmingham Clinical Trials Unit (BCTU)
School of Health & Population Sciences
College of Medical and Dental Sciences
Public Health Building
University of Birmingham
Birmingham B15 2TT


Fax: 0121 415 9135

Study Manager

  • Elizabeth Brettell - 0121 415 9130

Study Co-ordinator

  • Ryan Ottridge - 0121 415 9134/25

Data Manager

  • Adam Khan - 0121 415 9131


Find out more information about our other renal trials

The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit in the School of Medicine specialising in the design, conduct and analysis of clinical trials.

GloMY is national, multi-centre, randomised controlled open-label pilot trial of Myfortic plus short course steroids versus standard care in patients with proteinuric primary focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN).

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.

Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial

Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome.

STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.